
A member of the cardio-kidney-metabolic syndrome (CKM) guideline writing committee outlines steps pharmacists can take to ensure the kidney component of CKM is not overlooked.

Wendy L. St. Peter, PharmD, FCCP, FASN, FNKF, is professor emerita at the University of Minnesota College of Pharmacy and a writing committee member for the new cardio-kidney-metabolic (CKM) syndrome guideline.

A member of the cardio-kidney-metabolic syndrome (CKM) guideline writing committee outlines steps pharmacists can take to ensure the kidney component of CKM is not overlooked.

Wendy St Peter, PharmD, explains how the new cardio-kidney-metabolic (CKM) syndrome guideline supports pharmacist-led medication management, staging tools, and deprescribing.